Christopher Reyes

Christopher Reyes

Company: Bloom Science Inc.

Job title: Chief Executive Officer & Co-Founder, Director


Evaluating a Next Generation LBP Therapy for Patients with Dravet and ALS 12:45 pm

IrisRx – a platform for mechanistic based LBP drug development Rational selection of BL-001 strains in drug-resistant epilepsy and ALS Results of a pilot study with BL-001 in healthy volunteersRead more

day: Day One Track A AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.